An Oklahoma judge’s $572 million verdict against consumer products company Johnson & Johnson for its role in the state’s opioid crisis seems likely to be reduced on appeal.
But the verdict, along with Oklahoma’s prior settlement of another lawsuit against drug manufacturer Purdue Pharma, brings something else to mind.
